Global Opioid Drugs Market | Growth, Opportunity, Size, Share

1
The Global Opioid Drugs Market to Grow at a CAGR
of 2.56 by the year 2028
Triton Market Research presents the Global Opioid
Drugs Market report segmented by Product
(Buprenorphine, Fentanyl, Hydrocodone, Morphine,
Oxycodone, Tramadol, Other Products), by
Application (Pain Relief, Anesthesia, Cough
Suppression, Diarrhea Suppression, De-addiction),
by Geographical Region (North America, Europe,
Asia-Pacific, Latin America, Middle East and
Africa), discussing Market Summary, Industry
Outlook, Market Definition, Key Insights,
Porters Five Forces Analysis, Market
Attractiveness Index, Vendor Scorecard, Drivers,
Restraints, Opportunities, Challenges,
Competitive Landscape, Methodology Scope,
Global Market Size, Forecasts Analysis
(2020-2028).
Request for free sample report https//www.triton
marketresearch.com/reports/opioid-drugs-marketreq
uest-free-sample Triton Market Research has
forecasted the Global Opioid Drugs Market to
progress at a CAGR of 2.56 in the estimated
period (2020-2028). The adoption of opioid drugs
has witnessed immense growth. With this increased
adoption, opioid products have gained a major
market share in the pharmaceutical industry. The
commercial success achieved by these drugs and
the resultant increased market share are creating
growth opportunities for the studied market.
2
Furthermore, various companies have been making
heavy investments in RD and are incorporating
the latest technologies for optimizing drug
formulations. This factor has boosted the opioid
drugs demand and is taking it towards a growth
path. However, the opioid epidemic is spreading
at a quick rate. This has led to an increase in
the number of deaths due to opioid misuse and
overdose. These factors are challenging market
growth. North America is expected to witness the
highest growth rate in the global market over the
forecast period. With opioid drugs receiving
regulatory approvals, along with new
abuse-deterrent formulations being infused into
them, these drugs have witnessed a high demand.
Furthermore, the rise in the prices of both,
branded as well as generic drugs, is boosting the
growth of the regional market, owing to
increased profits. The enhanced expenditure in
pharmaceuticals is also another factor favoring
the North American opioid drugs market
growth. Pfizer Inc, Indivior Inc, Sanofi-Aventis
SA, Allergan (Acquired By Abbvie), Lupin Ltd,
Hikma Pharmaceuticals Plc, Johnson Johnson,
Lannett Co Inc, Purdue Pharma LP, Collegium
Pharmaceutical Inc, Sun Pharmaceutical
Industries Ltd, Mylan NV, Teva Pharmaceutical
Industries Ltd, Daiichi Sankyo, Janssen
Pharmaceuticals Inc, Cipher Pharmaceuticals Inc,
Acura Pharmaceuticals, and Biodelivery Sciences
International Inc are some of the reputed names
in the market. There is intense competition in
the global market for opioid drugs, owing to the
presence of numerous companies. The entry
barriers are also very high due to factors such
as stringent laws, manufacturing requirements,
and stringent marketing prescription laws
associated with these drugs. The legal, as well
as socio-political associated with the
manufacturing, supply, and distribution opioid
drugs are deterring new players from entering
the industry. Contact Us sales_at_tritonmarketresea
rch.com Phone [phone]